CIVALLERO, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.877
AS - Asia 1.672
EU - Europa 1.497
SA - Sud America 252
AF - Africa 59
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.364
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.818
SG - Singapore 519
CN - Cina 452
GB - Regno Unito 434
IT - Italia 328
VN - Vietnam 205
HK - Hong Kong 201
BR - Brasile 178
SE - Svezia 154
DE - Germania 130
RU - Federazione Russa 86
FI - Finlandia 82
UA - Ucraina 65
FR - Francia 63
TR - Turchia 51
BD - Bangladesh 40
KR - Corea 36
CA - Canada 32
IN - India 32
IE - Irlanda 28
ID - Indonesia 27
BG - Bulgaria 24
AR - Argentina 22
JP - Giappone 19
MA - Marocco 19
BE - Belgio 18
NL - Olanda 18
IQ - Iraq 16
MX - Messico 16
ZA - Sudafrica 16
EC - Ecuador 13
MY - Malesia 11
CL - Cile 10
AT - Austria 8
PE - Perù 8
PK - Pakistan 8
EG - Egitto 7
LB - Libano 7
LT - Lituania 7
PL - Polonia 7
SA - Arabia Saudita 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
ES - Italia 6
JO - Giordania 5
ET - Etiopia 4
PH - Filippine 4
PT - Portogallo 4
UY - Uruguay 4
AU - Australia 3
BO - Bolivia 3
CO - Colombia 3
IR - Iran 3
KE - Kenya 3
PR - Porto Rico 3
PY - Paraguay 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KW - Kuwait 2
KZ - Kazakistan 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
QA - Qatar 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AD - Andorra 1
AM - Armenia 1
BF - Burkina Faso 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GF - Guiana Francese 1
GR - Grecia 1
HU - Ungheria 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 7.357
Salva come PNG Salva come JPEG
Città #
Ashburn 519
Fairfield 375
Santa Clara 346
Singapore 329
Southend 304
Chandler 259
Woodbridge 236
Hong Kong 198
San Jose 184
Houston 161
Ann Arbor 130
Seattle 123
Cambridge 117
Nyköping 109
Wilmington 104
Beijing 86
Jacksonville 83
Hefei 82
London 80
Dearborn 78
Council Bluffs 62
Helsinki 61
New York 60
Modena 59
Ho Chi Minh City 58
The Dalles 57
Hanoi 54
Los Angeles 52
San Diego 40
Chicago 39
Milan 38
Seoul 36
Frankfurt am Main 31
Dublin 28
Izmir 27
Princeton 25
Moscow 24
Sofia 24
Fremont 22
Jakarta 22
Lauterbourg 22
Munich 22
Dallas 21
Shanghai 21
Eugene 19
São Paulo 19
Brussels 18
Salt Lake City 18
Casablanca 16
Cologno Monzese 16
Buffalo 15
Norwalk 12
Tokyo 12
Des Moines 10
Orem 10
Pisa 10
Atlanta 9
Columbus 9
Johannesburg 9
Miami 9
Montreal 9
San Giuliano Milanese 9
Boardman 8
Bremen 8
Falls Church 8
Lviv 8
Phoenix 8
Toronto 8
Amsterdam 7
Brusaporto 7
Chongqing 7
Da Nang 7
Haiphong 7
Naples 7
Nuremberg 7
Parma 7
Redondo Beach 7
Rome 7
San Francisco 7
Boston 6
Changsha 6
Dong Ket 6
Guangzhou 6
Lima 6
Redwood City 6
Baghdad 5
Bologna 5
Brasília 5
Brooklyn 5
Campinas 5
Caracas 5
Contagem 5
Kuala Lumpur 5
Lappeenranta 5
Latina 5
Ottawa 5
Quito 5
Rio de Janeiro 5
Tampa 5
Thái Nguyên 5
Totale 5.273
Salva come PNG Salva come JPEG
Nome #
Cell-penetrating CaCO3nanocrystals for improved transport of NVP-BEZ235 across membrane barrier in T-cell lymphoma 387
Activity of BKM120 and BEZ235 against lymphoma cells 369
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine 368
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 362
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 347
Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery 333
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines 303
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy 292
Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma 289
Genomic profiling of enzastaurin-treated B cell lymphoma RL cells 287
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases 284
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 281
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 277
Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts 275
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 268
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 253
Molecular targeting of the PKC-β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression 252
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination 233
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project 233
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project 230
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project 227
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas 202
COVID-related disruption in mammographic screening: a year later. 181
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project 180
Survival outcomes for extranodal natural-killer T-cell lymphoma – Authors' reply 168
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project 155
The Value and relevance of T-cell lymphoma registries 151
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network 149
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 59
Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study. 15
Preparing real-world data through common data model harmonization of cancer patient records in the COMNet platform at the Modena Oncology Center. 5
Totale 7.415
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 0 38
2021/2022555 36 29 63 29 9 64 36 22 44 46 107 70
2022/2023648 74 114 44 66 43 95 7 57 88 7 25 28
2023/2024421 18 24 18 50 82 34 43 47 5 17 48 35
2024/20251.230 50 11 36 103 233 179 96 68 120 43 102 189
2025/20262.482 176 84 165 227 323 188 343 145 274 251 261 45
Totale 7.415